Premstaetten, Austria (November 17, 2020) – ams (SIX: AMS), a leading worldwide supplier of high-performance sensor solutions, is driving efforts that will enable large-scale, fast, and highly reliable COVID-19 testing at the point of care (POC). The company’s spectral readout technology for Lateral Flow Immunoassays is used in PCR tests and now for antigen and antibody detection. Please join the upcoming virtual Fierce Technology Sensor Innovation Week Fall.

Tech Talk Keynote by ams AG:

• Delivering Pandemic Control: How ams innovation in spectral sensing technology is improving rapid access, accuracy, and app-to-cloud connectivity for COVID-19
• ams Featured Keynote Speaker: Wim Renirie, VP & General Manager for Accessory & Wearable Solutions
• Wednesday, November 18, 2020 / 11:30 am – Noon ET
• Register: The event is free; register here.

Abstract:

The capability to do large-scale, fast, and highly reliable testing at the point of care (POC) is key to overcoming the current pandemic situation. ams is driving these efforts forward through developing spectral readout technology for Lateral Flow Immunoassays for antigen (measuring saliva) and antibody (measuring blood) detection.

Since its initial development in the 1980s, Lateral Flow Test (LFT) technology has gained wide acceptance because the tests are compact and easy to use in a simple, cost-effective design. Vitally, they provide results within minutes without the need for laboratory equipment. However, their sensitivity as well as the possibility to provide deeper, quantitative results is limited when analyzed by the naked eye.

ams has developed a spectral readout module that addresses these challenges and drawbacks. Through spectral sensing, LFT test lines can now be objectively measured by a multi-channel sensor with spectral resolution, adding sensitivity and quantitative capabilities to the system without compromise on size, simplicity and fast, point-of-care results. In addition to improved measurement performance and user handling, the data can be digitized via an app and uploaded to the cloud, and therefore can become part of a pandemic monitoring system.

About the speaker:

Wim Renirie, VP & GM, Accessory & Wearable Solutions. Mr. Renirie holds a PhD in electrical engineering from the Technical University in Delft, the Netherlands. He holds two U.S. patents and has more than 25 years’ experience in the semiconductor industry. At ams his department is responsible for innovations and product developments in vital, spectral, and audio sensors.

About the Event:

Fierce Technology’s Sensors Innovation Week Fall is a free, three-day virtual event being held on November 16 –18, 2020. It features dozens of speakers from across the sensors industry to define, discuss, and understand design challenges and sensor solutions. Each day will feature networking, keynotes, tech talks, breakout sessions, panels, and more.

Please click here for more information on the event.

About ams

ams is a global leader in the design and manufacture of advanced sensor solutions. Our mission is to shape the world with sensor solutions by providing a seamless interface between humans and technology.

ams’ high-performance sensor solutions drive applications requiring small form factor, low power, highest sensitivity and multi-sensor integration. Products include sensor solutions, sensor ICs, interfaces and related software for consumer, communications, industrial, medical, and automotive markets.

With headquarters in Austria, ams employs around 9,000 people globally and serves more than 8,000 customers worldwide. ams is listed on the SIX Swiss Exchange (ticker symbol: AMS). More information about ams can be found at https://ams.com

Join ams social media channels: >Twitter  >LinkedIn   >Facebook   >YouTube

ams is a registered trademark of ams AG. In addition many of our products and services are registered or filed trademarks of ams Group. All other company or product names mentioned herein may be trademarks or registered trademarks of their respective owners. Information provided in this press release is accurate at time of publication and is subject to change without advance notice.